Scarica l'app Stockscreener
2.7851
2.10%
-0.0249
Qualigen Therapeutics Inc Azioni (QLGN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
38.20%
1.6837
|
2.7247 | 1.333 | 1.2686 | 1.7408 |
| Operating Income/Loss |
38.20%
-1.6837
|
-2.7247 | -1.333 | -1.2686 | -1.7408 |
| Nonoperating Income/Loss |
102.13%
-0.00167
|
0.0786 | 0.4828 | -0.5277 | 0.263 |
| Income/Loss From Continuing Operations Before Tax |
36.31%
-1.6854
|
-2.6461 | -0.8503 | -1.7963 | -1.4778 |
| Income/Loss From Continuing Operations After Tax |
36.31%
-1.6854
|
-2.6462 | -0.8558 | -1.7941 | -1.4766 |
|
Net Income/Loss
|
36.31%
-1.6854
|
-2.6462 | -0.8558 | -1.7941 | -1.5766 |
| Preferred Stock Dividends And Other Adjustments |
0.00159
|
- | - | 0.0276 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
15.59%
1.6839
|
1.4567 | - | - | 7.6033 |
| Diluted Average Shares |
15.59%
1.6839
|
1.4567 | 0.1414 | 0.3879 | 7.6033 |
| Basic Earnings Per Share |
45.05%
-1.00
|
-1.82 | - | - | -0.21 |
| Diluted Earnings Per Share |
45.05%
-1.00
|
-1.82 | 7.38 | -4.70 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.00159
|
- | - | 0.0276 | - |
1.18%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):